{"id":48080,"date":"2022-09-07T23:01:45","date_gmt":"2022-09-07T21:01:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/"},"modified":"2022-09-07T23:01:45","modified_gmt":"2022-09-07T21:01:45","slug":"exaktera-announces-acquisition-of-advanced-illumination-inc","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/","title":{"rendered":"Exaktera Announces Acquisition of Advanced Illumination Inc."},"content":{"rendered":"
\n

BOSTON–(BUSINESS WIRE)–Exaktera LLC, (\u201cExaktera\u201d), a Union Park Capital (\u201cUnion Park\u201d) portfolio company, is pleased to announce its acquisition of Advanced Illumination Inc. (\u201cAdvanced Illumination\u201d), a long-established design and manufacturer of specialty LED lighting assemblies and drivers for machine vision, industrial imaging, bio-medical and related imaging applications. Terms of the transaction were not disclosed.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nAdvanced Illumination\u2019s state-of-the-art LED components, current mode drivers and strobe sources, combined with optical and thermal design techniques enable factory automation and machine vision across a wide variety of industrial applications. Established in 1993, Advanced Illumination has partnered with industry leading integrators, distributors and OEMs to solve end users illumination needs and solving their most challenging advanced lighting challenges.\n<\/p>\n

\n\u201cWe are very excited to have Advanced Illumination join the Exaktera family,\u201d says Phil Martin, CEO Exaktera. \u201cThe company\u2019s product portfolio in specialty LED solutions and expertise in machine vision is highly complementary to Exaktera\u2019s existing capabilities. Their technical leadership and deep application knowledge strengthens our overall capabilities and will allow us to best serve our customers.\u201d\n<\/p>\n

\nJohn Thrailkill will continue in his key leadership role as President of Advanced Illumination. \u201cThe transaction is a tremendous opportunity for Advanced Illumination and its employees to grow to the next level leveraging global resources under the Exaktera umbrella. With Exaktera we have found a great home to ensure future success,\u201d added Mr. Thrailkill. \u201cThe synergies of products, technical resources, and global sales will significantly enhance the value we can provide our customers and ensure we continue to solve the most demanding machine vision illumination challenges.\u201d\n<\/p>\n

\nAbout Advanced Illumination Inc.
\n
<\/b>Advanced Illumination was established in 1993 and is headquartered in Rochester, Vermont. The company offers its customers complete illumination solution for their unique lighting requirements. With its extensive experience in design and manufacturing LED solutions, Advanced Illumination has developed unique expertise to solve the most difficult lighting challenges for its customers. For more information visit www.advancedillumination.com<\/a>.\n<\/p>\n

\nAbout Exaktera LLC
\n
<\/b>\u200b<\/strong>Exaktera, a portfolio company of Union Park Capital, is focused on critical components that define the precision performance for OEMs. Exaktera\u2019s premium brands are used across a wide range of applications and end markets to enable continuously increasing demand for machine vision, automation and enable improvements in efficiency, productivity, and safety. More information can be found visiting www.exaktera.com<\/a>.\n<\/p>\n

\nAbout Union Park Capital
\n
<\/strong>Union Park Capital is a private equity firm solely focused on lower middle-market industrial technology companies. Union Park takes a long-term perspective to help stakeholders build value over time and drives value creation through profitably growing a business, not financial engineering. Union Park Capital is based in Boston, MA, and has extensive investments and expertise in the industrial technology sector. For more information visit www.union-park.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nGeorg Lauble
\n
phone ++49 1795215541\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BOSTON–(BUSINESS WIRE)–Exaktera LLC, (\u201cExaktera\u201d), a Union Park Capital (\u201cUnion Park\u201d) portfolio company, is pleased to announce its acquisition of Advanced Illumination Inc. (\u201cAdvanced Illumination\u201d), a long-established design and manufacturer of specialty LED lighting assemblies and drivers for machine vision, industrial imaging, bio-medical and related imaging applications. Terms of the transaction were not disclosed. Advanced Illumination\u2019s … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48080","6":"format-standard","7":"category-industry"},"yoast_head":"\nExaktera Announces Acquisition of Advanced Illumination Inc. - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exaktera Announces Acquisition of Advanced Illumination Inc. - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOSTON–(BUSINESS WIRE)–Exaktera LLC, (\u201cExaktera\u201d), a Union Park Capital (\u201cUnion Park\u201d) portfolio company, is pleased to announce its acquisition of Advanced Illumination Inc. (\u201cAdvanced Illumination\u201d), a long-established design and manufacturer of specialty LED lighting assemblies and drivers for machine vision, industrial imaging, bio-medical and related imaging applications. Terms of the transaction were not disclosed. Advanced Illumination\u2019s ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-07T21:01:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220907006215\/en\/1564681\/21\/Exaktera_News_220830.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Exaktera Announces Acquisition of Advanced Illumination Inc.\",\"datePublished\":\"2022-09-07T21:01:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/\"},\"wordCount\":466,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006215\\\/en\\\/1564681\\\/21\\\/Exaktera_News_220830.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/\",\"name\":\"Exaktera Announces Acquisition of Advanced Illumination Inc. - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006215\\\/en\\\/1564681\\\/21\\\/Exaktera_News_220830.jpg\",\"datePublished\":\"2022-09-07T21:01:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006215\\\/en\\\/1564681\\\/21\\\/Exaktera_News_220830.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220907006215\\\/en\\\/1564681\\\/21\\\/Exaktera_News_220830.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exaktera-announces-acquisition-of-advanced-illumination-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exaktera Announces Acquisition of Advanced Illumination Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exaktera Announces Acquisition of Advanced Illumination Inc. - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/","og_locale":"en_US","og_type":"article","og_title":"Exaktera Announces Acquisition of Advanced Illumination Inc. - Pharma Trend","og_description":"BOSTON–(BUSINESS WIRE)–Exaktera LLC, (\u201cExaktera\u201d), a Union Park Capital (\u201cUnion Park\u201d) portfolio company, is pleased to announce its acquisition of Advanced Illumination Inc. (\u201cAdvanced Illumination\u201d), a long-established design and manufacturer of specialty LED lighting assemblies and drivers for machine vision, industrial imaging, bio-medical and related imaging applications. Terms of the transaction were not disclosed. Advanced Illumination\u2019s ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-07T21:01:45+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220907006215\/en\/1564681\/21\/Exaktera_News_220830.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Exaktera Announces Acquisition of Advanced Illumination Inc.","datePublished":"2022-09-07T21:01:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/"},"wordCount":466,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220907006215\/en\/1564681\/21\/Exaktera_News_220830.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/","url":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/","name":"Exaktera Announces Acquisition of Advanced Illumination Inc. - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220907006215\/en\/1564681\/21\/Exaktera_News_220830.jpg","datePublished":"2022-09-07T21:01:45+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220907006215\/en\/1564681\/21\/Exaktera_News_220830.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220907006215\/en\/1564681\/21\/Exaktera_News_220830.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/exaktera-announces-acquisition-of-advanced-illumination-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Exaktera Announces Acquisition of Advanced Illumination Inc."}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48080","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48080"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48080\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48080"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48080"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48080"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}